KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Total Current Liabilities (2018 - 2026)

Takeda Pharmaceutical has reported Total Current Liabilities over the past 9 years, most recently at $15.5 billion for Q1 2026.

  • For Q1 2026, Total Current Liabilities fell 5.7% year-over-year to $15.5 billion; the TTM value through Mar 2026 reached $15.5 billion, down 5.7%, while the annual FY2026 figure was $16.1 billion, 1.91% down from the prior year.
  • Total Current Liabilities was $15.5 billion for Q1 2026 at Takeda Pharmaceutical, down from $16.4 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $18.8 billion in Q1 2023 and bottomed at $15.5 billion in Q1 2026.
  • The 5-year median for Total Current Liabilities is $16.4 billion (2025), against an average of $17.0 billion.
  • Year-over-year, Total Current Liabilities rose 10.22% in 2022 and then decreased 16.81% in 2024.
  • Over 5 years, Total Current Liabilities stood at $18.5 billion in 2022, then increased by 1.62% to $18.8 billion in 2023, then decreased by 16.81% to $15.6 billion in 2024, then increased by 5.26% to $16.4 billion in 2025, then decreased by 5.7% to $15.5 billion in 2026.
  • The last three reported values for Total Current Liabilities were $15.5 billion (Q1 2026), $16.4 billion (Q1 2025), and $15.6 billion (Q1 2024) per Business Quant data.